RAD50 expression (ref. low) was associated with OS in AHYMUM patients (HR: 6.807; p < 0.001) but was not markedly correlated with OS in HCC patients from the AHNTU (HR: 1.735; p = 0.195) cohort. Here, RAD50 is linked to hepatocellular carcinoma.